Lipid phosphatase SAC1 suppresses hepatitis B virus replication through promoting autophagic degradation of virions

Jiaxin Zheng,Yingying Deng,Zhen Wei,Hecun Zou,Xiang Wen,Jia Cai,Shujun Zhang,Bei Jia,Mengji Lu,Kefeng Lu,Yong Lin
DOI: https://doi.org/10.1016/j.antiviral.2023.105601
IF: 7.6
2023-04-17
Antiviral Research
Abstract:Phosphatidylinositol lipids play vital roles in lipid signal transduction, membrane recognition, vesicle transport, and viral replication. Previous studies have revealed that SAC1-like phosphatidylinositol phosphatase (SACM1L/SAC1), which uses phosphatidylinositol-4-phosphate (PI4P) as its substrate, greatly affects the replication of certain bacteria and viruses in vitro . However, it remains unclear whether and how SAC1 modulates hepatitis B virus (HBV) replication in vitro and in vivo . In the present study, we observed that SAC1 silencing significantly increased HBV DNA replication, subviral particle (SVP) expression, and secretion of HBV virions, whereas SAC1 overexpression exerted the opposite effects. Moreover, SAC1 overexpression inhibited HBV DNA replication and SVP expression in a hydrodynamic injection-based HBV-persistent replicating mouse model. Mechanistically, SAC1 silencing increased the number of HBV-containing autophagosomes as well as PI4P levels on the autophagosome membrane. Moreover, SAC1 silencing blocked autophagosome-lysosome fusion by inhibiting the interaction between synaptosomal-associated protein 29 and vesicle-associated membrane protein 8. Collectively, our data indicate that SAC1 significantly inhibits HBV replication by promoting the autophagic degradation of HBV virions. Our findings support that SAC1-mediated phospholipid metabolism greatly modulates certain steps of the HBV life-cycle and provide a new theoretical basis for antiviral therapy.
pharmacology & pharmacy,virology
What problem does this paper attempt to address?